Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Ovarian Neoplasms 23Peritoneal Neoplasms 15Fallopian Tube Neoplasms 10Colorectal Neoplasms 8Stomach Neoplasms 6Carcinoma, Ovarian Epithelial 5Neoplasms 3Sarcoma 2Rhabdomyosarcoma 2Recurrence 2Glioma 2Glioblastoma 2Gastrointestinal Neoplasms 2Desmoplastic Small Round Cell Tumor 2Colonic Neoplasms 2Brain Neoplasms 2Appendiceal Neoplasms 2Adrenocortical Carcinoma 2Adenoma, Islet Cell 2Wilms Tumor 1Retroperitoneal Neoplasms 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Postoperative Complications 1Peritoneal Cavity Cancer 1Peritoneal Cancer 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Oligodendroglioma 1Neuroblastoma 1

Interventions

Temozolomide 44Radiotherapy 20Magnetic Resonance Spectroscopy 13Irinotecan 13Carboplatin 11Bevacizumab 11Filgrastim 9Surgical Procedures, Operative 7Procarbazine 6sargramostim 5Vincristine 5Imatinib Mesylate 5Etoposide 5Erlotinib Hydrochloride 5Carmustine 5Biopsy 5etoposide phosphate 4Peripheral Blood Stem Cell Transplantation 4Lomustine 4Immunohistochemistry 4Cyclophosphamide 42-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 4temsirolimus 3poly ICLC 3aldesleukin 3Thalidomide 3Surveys and Questionnaires 3Radiation 3Polymerase Chain Reaction 3Gadolinium DTPA 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Oligodendroglioma × Cytoreduction Surgical Procedures × Clear all
NCT02238496 2023-05-25

Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas

Columbia University

Phase 1 Completed
10 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡